The American Surgeon · 1999 · 42 citations · 16 references
MedicineSurgeryGastroenterologyGeneral SurgerySurgical PathologyPancreatic CancerPancreatic DiseasesPancreatic DisordersPancreatic PathologyPancreatic SurgeryChronic Pancreatitis ManagementMedical IndicationPancreatic Biliary DiseasePostoperative Length Of StaySurgical Pancreatic InterventionT-testWhipple Disease
There have been increasing changes in the role of pancreatoduodenectomy (PD) in the management of benign and malignant pancreatic disease. The aim of this paper was to compare the current role of PD with that of our earlier experience. The records of patients undergoing PD at our institution between 1983 and 1996 (Group A) were reviewed and compared with cases between 1956 and 1982 (Group B). Student's t test was used to analyze differences between groups. A total of 153 PDs were performed with 98 (64%) in Group A (88% of these in the last 6 years) and 55 (36%) in Group B. Carcinoma of the head of the pancreas was the most common indication for surgery in both periods (43% and 47% for Groups A and B, respectively). In Group A, the next most common indication was chronic pancreatitis, accounting for 28 per cent versus 13 per cent in Group B. Carcinoma of ampulla of Vater was also a common indication, making up 21 per cent of the cases in Group A and 20 per cent in Group B. Preoperative biliary drainage was performed in 62 per cent of Group A and 3 per cent of Group B patients (P < 0.001). Postoperative complications were comparable in both groups: delayed gastric emptying (22%), wound infection (17%), pancreatic fistula (13%), gastrointestinal bleeding (8%), and intestinal obstruction (3%). The perioperative mortality rate was significantly different between the two groups: 1 per cent in Group A versus 16 per cent in Group B (P < 0.001). Mean postoperative length of stay was 17 days in Group A (22 days for benign disease) and 25 days for Group B (P < 0.01). In the last 40 years, there has been a rise in the use of PD for chronic pancreatitis and a significant decrease in postoperative mortality and hospital length of stay. These data support the safety of PD in the management of patients with both benign and malignant periampullary disease.
16
TEEATMENT OF CARCINOMA OF THE AMPULLA OF VATER
Allen O. Whipple, William Barclay Parsons, Clinton R. Mullins · Annals of Surgery · 1935 · 1.4K citations · Full text
One Hundred and Forty-Five Consecutive Pancreaticoduodenectomies Without Mortality
John L. Cameron, Henry A. Pitt, Charles J. Yeo et al. · Annals of Surgery · 1993 · 801 citations
Standards for Pancreatic Resection in the 1990s
Carlos Fernández‐del Castillo · Archives of Surgery · 1995 · 475 citations
Medicine, Surgery, Gastroenterology +16